XML 95 R10.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Inventory | 12 Months Ended
--- | ---
Dec. 31, 2014
Inventory | (4) Inventory After approval of Vascepa on July 26, 2012 by the FDA, the Company began capitalizing its purchases of saleable inventory of Vascepa from suppliers that have been qualified by the FDA. Inventories consist of the following (in thousands):
|  | December 31, 2014 |  |  | December 31, 2013 |
Raw materials, current |  | $ | 5,225 |  |  | $ | 4,246 |
Work in process |  |  | 4,757 |  |  |  | 11,310 |
Finished goods |  |  | 3,751 |  |  |  | 5,026 |
Finished goods inventory held by others |  |  | — |  |  |  | 627 |
Total inventory, current |  |  | 13,733 |  |  |  | 21,209 |
Raw materials, long-term |  |  | — |  |  |  | 5,482 |
Total inventory |  | $ | 13,733 |  |  | $ | 26,691 |
During the years ended December 31, 2014 and 2013, the Company wrote off zero and $1.8 million, respectively, of inventories deemed to be unrecoverable. In addition, as of December 31, 2014 and 2013, zero and $5.5 million, respectively, of raw material inventory was reclassified to long-term inventory, as it was not anticipated to be sold within the next twelve months based on current estimates.

X
- Definition The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 6 -Subparagraph a, b, c -Article 5 + Details
Name: | us-gaap_InventoryDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration